CM
Caption Management Portfolio holdings
AUM
$1.09B
This Quarter Return
+1.45%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$908M
AUM Growth
+$908M
(-1.3%)
Cap. Flow
-$35.9M
Cap. Flow
% of AUM
-3.96%
Top 10 Holdings %
Top 10 Hldgs %
45.15%
Holding
1,012
New
186
Increased
87
Reduced
75
Closed
257
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$19.4M |
| 2 |
Meta Platforms (Facebook)
META
|
$16.3M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$15.7M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$13.8M |
| 5 |
Pilgrim's Pride
PPC
|
$12.6M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$21.3M |
| 2 |
Palo Alto Networks
PANW
|
$19.6M |
| 3 |
Cigna
CI
|
$16.5M |
| 4 |
Charter Communications
CHTR
|
$14.3M |
| 5 |
NextEra Energy, Inc.
NEE
|
$11.4M |
Sector Composition
| 1 | Healthcare | 19.84% |
| 2 | Communication Services | 18.73% |
| 3 | Financials | 15.67% |
| 4 | Technology | 11.62% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Vertex Pharmaceuticals
VRTX
$102B
| $1.45M | 0.02% |
+3,480
| New | +$1.45M |
|
127
IBM
IBM
$227B
| $1.43M | 0.02% |
+7,500
| New | +$1.43M |
|
128
Ascendis Pharma
ASND
$12.1B
| $1.42M | 0.02% |
+9,426
| New | +$1.42M |
|
129
Pacira BioSciences
PCRX
$1.22B
| $1.42M | 0.02% |
48,598
+35,900
| +283% | +$1.05M |
|
130
American Airlines Group
AAL
$8.87B
| $1.41M | 0.02% |
+91,800
| New | +$1.41M |
|
131
Aspen Aerogels
ASPN
$549M
| $1.41M | 0.02% |
80,048
+68,128
| +572% | +$1.2M |
|
|
ARCH
132
DELISTED
Arch Resources, Inc.
ARCH
| $1.41M | 0.02% |
8,761
-13,500
| -61% | -$2.17M |
|
133
Arrowhead Research
ARWR
$3.84B
| $1.4M | 0.02% |
49,000
+98
| +0.2% | +$2.8K |
|
134
JPMorgan Chase
JPM
$824B
| $1.38M | 0.02% |
+6,900
| New | +$1.38M |
|
135
Allot
ALLT
$388M
| $1.36M | 0.02% |
602,522
-37,639
| -6% | -$85.1K |
|
136
Zoom
ZM
$25B
| $1.35M | 0.02% |
20,705
+5,955
| +40% | +$389K |
|
137
iShares US Real Estate ETF
IYR
$3.7B
| $1.35M | 0.02% |
15,000
-37,000
| -71% | -$3.33M |
|
138
QuidelOrtho
QDEL
$1.87B
| $1.34M | 0.02% |
28,039
-10,261
| -27% | -$492K |
|
139
Pinduoduo
PDD
$177B
| $1.33M | 0.02% |
11,400
+7,996
| +235% | +$930K |
|
140
PureCycle Technologies
PCT
$2.39B
| $1.24M | 0.02% |
200,000
+199,823
| +112,894% | +$1.24M |
|
141
Kroger
KR
$45.1B
| $1.24M | 0.02% |
21,700
+9,840
| +83% | +$562K |
|
142
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.23M | 0.02% |
+66,600
| New | +$1.23M |
|
143
Dave & Buster's
PLAY
$838M
| $1.12M | 0.02% |
17,900
-30,408
| -63% | -$1.9M |
|
144
Cameco
CCJ
$33.6B
| $1.11M | 0.02% |
+25,700
| New | +$1.11M |
|
145
JD.com
JD
$44.2B
| $1.1M | 0.02% |
40,000
+1,000
| +3% | +$27.4K |
|
146
Charles Schwab
SCHW
$175B
| $1.09M | 0.02% |
+15,000
| New | +$1.09M |
|
147
Larimar Therapeutics
LRMR
$337M
| $1.08M | 0.02% |
+142,900
| New | +$1.08M |
|
148
Phreesia
PHR
$1.81B
| $1.08M | 0.02% |
45,000
+26,500
| +143% | +$634K |
|
149
Travel + Leisure Co
TNL
$4.06B
| $1.03M | 0.02% |
+21,000
| New | +$1.03M |
|
150
WESCO International
WCC
$10.6B
| $1.03M | 0.02% |
+6,000
| New | +$1.03M |
|